医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

AllAccem Announces Human Dental Product Presentation at the 2017 IADR/AADR/CADR General Session & Exhibition

2017年03月14日 PM10:09
このエントリーをはてなブックマークに追加


 

SAN CARLOS, Calif.

AllAccem, Inc., a pharmaceutical and medical device products developer and manufacturer, announced today that Karin M. Hold, PhD is presenting the poster titled “Biocompatibility of AllAccem Gingival Sealant, a New Prescription Dental Device” (Poster # 1349), on Thursday, March 23 at 3:45 PM PDT at the 95th General Session & Exhibition of the International Association for Dental Research (IADR) in conjunction with the 46th Annual Meeting of the American Association for Dental Research (AADR) and the 41st Annual Meeting of the Canadian Association for Dental Research (CADR) to be held at the Moscone Center in San Francisco, CA on March 22-25, 2017. Biocompatibility and safety results that AllAccem Gingival Sealant has generated to date indicate potential use as a prescription dental device.

About AllAccem Gingival Sealant

AllAccem Gingival Sealant is a professionally applied human dental product that is in development as an aid in the treatment of gingivitis by inhibiting bacterial adhesion to tooth surfaces. The Sealant contains a proprietary polymer (012-38) that presents a surface barrier preventing oral bacteria forming dental plaque from adhering to and colonizing on tooth surfaces at the gingival margin and gingival sulcus.

About AllAccem, Inc.

AllAccem is a medical device and pharmaceutical company that develops products for veterinary and human health care derived from the Company’s proprietary chemistry platform. AllAccem, Inc. currently manufactures, markets and sells the professional veterinary care products SANOS®, OticArmor® and CutoGuard®. AllAccem, Inc. is a privately held US corporation founded in 2005. AllAccem is focused on providing innovative approaches to existing medical device and pharmaceutical development challenges. For more information, visit http://www.allaccem.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170314005346/en/

CONTACT

AllAccem, Inc.
Jeffery A. Whiteford, PhD, 650-593-8701
Chief
Executive Officer

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 美泰上市全球最先进的人参补剂
  • SpinalCyteが新たな日本国特許を取得
  • Together for Safer Roads任命 David Braunstein担任总裁
  • マシモ、rainbow®対応の多派長脈波変動指標となる非侵襲的RPVi™のCEマーク取得を発表
  • Masimo宣布rainbow®多波长脉搏灌注变异指数无创RPVi™获得CE标记